Table 1. Top 10 drugs selected by PDX screening.
PhLO viability (%) | Relative MTT value of ALL1 | Relative MTT value of S17 | |
---|---|---|---|
Pentoxifylline | 0 | 0.46 | 0.87 |
Rilmenidine hemifumarate | 0 | 0.66 | 0.75 |
AC-93253 iodide | 0 | 0.29 | 0.83 |
Idarubicin | 0 | 0.26 | 0.82 |
Chicago sky blue 6B | 0 | 0.91 | 0.55 |
Pyrvinium pamoate | 0 | 0.34 | 0.38 |
Aurantimycin A | 0 | 0.21 | 0.29 |
Verteporfin Stattic | 0.01 9.9 | 1.08 0.19 | 0.3 0.69 |